Register now to R3i !
Your Login
Your Password
Confirm Password  
Your Email
The initiative

Prof. Christoph Wanner

Prof. Christoph Wanner  
University Hospital Würzburg,
Germany
 
Current position
 
1994 - Professor of Medicine, Chief, Division of Nephrology, Dept of Medicine and Scientific director, Clinical Trial Unit, University Hospital of Würzburg Julius-Maximilians-University, Würzburg, Germany
 
Past position
 
1991 Assistant Professor and faculty member
1992 Research sebatical at the NIH, NHLBI, Molecular Disease Branch (B. Brewer), USA
 
Scientific training
 
1983 - 1989 Residency and internship at the Universities of Zurich, Switzerland and Freiburg, Germany
1990 Habilitation (equivalent to PhD)
 
Professional Associations
 
  Steering committee member and central Europe coordinator of SHARP (study of heart and renal protection).
 
Publicatins (selection)
 
R3i related paper:
Wanner C, Krane V, März W, Olschewski M, Mann JFE, Ruf G, Ritz E for the German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. New Engl J Med 2005;353:238-248
 
Best cited paper (710 citations):
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658
 
Research
 
Scientific areas of interest are :
(1) the role of lipids in the progression of renal and vascular disease (glomerulosclerosis and atherosclerosis in kidney failure patients)
(2) elucidation of the inflammatory response syndrome in diabetic nephropathy, chronic kidney disease and kidney failure. 1998-2005 PI of the 4D study, a statin outcome trial in diabetic patients on dialysis